Clinical Research & Clinical Trial Management | Project Owner

How Many Software Systems Does One Clinical Trial Actually Need? Ask someone outside the industry to guess how many software systems a single clinical trial runs on, and they'll probably say two or three: something to collect patient data, something to manage the study. Ask someone who actually staffs a site, and the answer is closer to twenty. This isn't exaggeration. It's documented, repeatedly, across multiple independent industry surveys. And once you start counting, the financial and human cost of that sprawl becomes hard to ignore. The inventory: what actually runs a trial A realistic multi-site trial typically touches systems across at least six layers: Core eClinical systems EDC (Electronic Data Capture) for patient-level data collection CTMS (Clinical Trial Management System) for enrollment, site performance, milestones, budgets RTSM/IRT for randomization and drug supply management eTMF for trial master file / regulatory document repository eConsen...

Ask most people in clinical research whether a trial protocol is confidential, and the answer comes fast: "Of course it is." Ask a regulator, and the answer is more precise: parts of it are, and increasingly, large parts are not. This distinction matters for far more than curiosity. It shapes how project teams can share documents with vendors, how patients and advocacy groups can review what a trial actually involves, and, as explored in an earlier piece on this blog about protocols and generative AI , what can safely be uploaded into an AI tool in the first place. This article stays deliberately narrower: not the AI question, but the underlying regulatory one. What does the law and GCP framework actually say is public, and what stays behind closed doors? Confidentiality has a formal definition: it's narrower than people assume. ICH's Good Clinical Practice guideline doesn't treat "the protocol" as a single confidential object. It defines confiden...

As large language models (LLMs), GenAI, workflow automation, and integrated operational platforms continue to evolve, an increasingly uncomfortable question is beginning to emerge within clinical research: Why are so many additional organizational, management, and software layers still required to run clinical trials? For decades, CROs have played a central role in pharmaceutical research. Historically, this made complete sense. Pharmaceutical companies needed global operational infrastructure, therapeutic expertise, monitoring capacity, regulatory operations, staffing, laboratory services, and the ability to rapidly execute increasingly complex multinational clinical trials. However, modern clinical trial operations have also become heavily fragmented. Today, Sponsors, CROs, vendors, laboratories, and sites often maintain overlapping operational systems, duplicated reporting layers, reconciliation trackers, parallel oversight structures, and multiple disconnected software environments...

(Please drop a comment or reach out if you would like to discuss the development of this concept, exchange ideas, validate assumptions, or explore potential collaboration opportunities.) Over the last weeks, I have been experimenting with AI-assisted development platforms such as Codex and Base44 to explore whether integrated clinical trial budgeting and operational planning concepts can now be prototyped much faster than traditionally possible with multiple disconnected systems. As an educational proof-of-concept, I used publicly available clinical trial protocol examples to generate prototype Clinical Trial Budgeting and Project Management environments (links below). The broader goal is not to create a validated production system at this stage, but rather to explore whether a lightweight educational platform could eventually help research groups, startups, CROs, and biotech teams: estimate study budgets, evaluate operational feasibility, understand budget drivers, model resource requ...

Many newcomers to clinical research ask a surprisingly modern question: If generative AI can read long documents, summarize complexity, detect inconsistencies, build schedules, and help teams prepare faster: - why can’t project teams simply upload a clinical trial protocol?

 A Practical Guide for Students and Future Trial Participants Clinical research uses many technical abbreviations, but few are as important as ICF , which stands for Informed Consent Form . Although often described simply as “a form to sign,” this is only part of the picture. In reality, the ICF is one of the core ethical safeguards in modern human research. An Informed Consent Form is the document, and more importantly, the communication process, through which a potential participant receives information about a clinical study before deciding whether to join. It is intended to help a person understand what the study is about, what participation may involve, what risks may exist, what possible benefits may or may not occur, and what rights remain with the participant throughout the study. In simple terms, the ICF is where science meets human choice. Examples of Informed Consent Forms (ICF) Students often ask what an actual Informed Consent Form looks like in practice. Below are ...

Clinical trials are essential for developing new medicines, but they require coordination across many different participants, including sponsors, hospitals, and regulatory authorities. One of the most important—yet often less understood—participants in this process is the Contract Research Organization (CRO) . A Contract Research Organization is a company that provides services to support the planning, management, and execution of clinical trials. CROs play a key role in helping sponsors run studies efficiently, especially when trials involve multiple countries, sites, and complex regulatory requirements. What Does a Contract Research Organization Do?